landmark NIH hypertension study will shake things up
The surprising results from the landmark NIH hypertension study will shake things up.
The "modern" ACE inhibitors, calcium channel blockers, and beta-blockers won't be first choice for most patients anymore.
The huge ALLHAT study shows that a good old diuretic is often better.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: PA includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote